deltatrials
Completed NA INTERVENTIONAL 1-arm NCT04309149

Market Research - Acceptability Study for a Range of MCT Products

Market Research - Acceptability Study for a Range of New MCT Based Products (Dr Schär - Kanso MCT) Kanso MCT 100% Oil Kanso MCT 77% Oil Kanso MCT 83% Margarine

Sponsor: Dr. Schär AG / SPA

Conditions Epilepsy Fatty Acid Oxidation Disorder Ketogenic Diet Ketosis Malabsorption
Interventions MCT fats
Updated 4 times since 2020 Last updated: Mar 12, 2020 Started: Nov 1, 2018 Primary completion: Jan 31, 2020 Completion: Jan 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Epilepsy and Fatty Acid Oxidation Disorder and is currently completed. Dr. Schär AG / SPA leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Apr 2020 — Jan 2021 [monthly]

    Completed NA

    First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dr. Schär AG / SPA
Data source: Dr. Schär AG / SPA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations